Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines (original) (raw)
Angel P and Karin M (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta1072: 129–157 CASPubMed Google Scholar
Angel P, Baumann I, Stein B, Delius H, Rahmsdorf HJ and Herrlich P (1987a) 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol Cell Biol7: 2256–2266 ArticleCASPubMedPubMed Central Google Scholar
Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P and Karin M (1987b) Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell49: 729–739 ArticleCASPubMed Google Scholar
Astruc ME, Chabret C, Bali P, Gagne D and Pons M (1995) Prolonged treatment of breast cancer cells with antiestrogens increases the activating protein-1-mediated response: involvement of the estrogen receptor. Endocrinology136: 824–832 ArticleCASPubMed Google Scholar
Borner CR, Wyss R, Regazzi RUE and Fabbro D (1987) Immunological quantitation of phospholipid/Ca2+-dependent protein kinase of human mammary carcinoma cells: inverse relationships to estrogen receptors. Int J Cancer40: 344–348 ArticleCASPubMed Google Scholar
Catherino WH and Jordan VC (1995) Increasing the number of tandem estrogen response elements increases the estrogenic activity of a tamoxifen analogue. Cancer Lett92: 39–47 ArticleCASPubMed Google Scholar
Chen TK, Smith LM, Gebhardt DK, Birrer MJ and Brown PH (1996) Activation and inhibition of the AP-1 complex in human breast cancer cells. Mol Carcinog15: 215–226 ArticleCASPubMed Google Scholar
Davidson N and Kennedy M (1996) Protein kinase C and breast cancer. In: R D). and M, L. (eds) Mammary tumor cell cycle, differentiation and metastasis pp. 91–105. Kluwer Academic Pubishers. Chapter Google Scholar
Dekker LV and Parker PJ (1994) Protein kinase C–a question of specificity. Trends Biochem Sci19: 73–77 ArticleCASPubMed Google Scholar
Dumont JA, Bitoni AJ, Wallace CD, Baumann RJ, Cashman EA and Cross-Doersen DE (1996) Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity. Cell Growth Differ7: 351–359 CASPubMed Google Scholar
Encarnacion CA, Ciocca DR, McGuire WL, Clark GM, Fuqua SA and Osborne CK (1993) Measurement of steroid hormone receptors in breast cancer patients on tamoxifen. Breast Cancer Res Treat26: 237–246 ArticleCASPubMed Google Scholar
Gordge PC, Hulme MJ, Clegg RA and Miller WR (1996) Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue. Eur J Cancer32A: 2120–2216 ArticleCASPubMed Google Scholar
Hata A, Akita Y, Suzuki K and Ohno S (1993) Functional divergence of protein kinase C (PKC) family members. PKC gamma differs from PKC alpha and -beta II and nPKC epsilon in its competence to mediate-12-O-tetradecanoyl phorbol 13-acetate (TPA)- responsive transcriptional activation through a TPA-response element. J Biol Chem268: 9122–9129 CASPubMed Google Scholar
Jiang SY, Wolf DM, Yingling JM, Chang C and Jordan VC (1992) An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol. Mol Cell Endocrinol90: 77–86 ArticleCASPubMed Google Scholar
Johnson MD, Torri JA, Lippman ME and Dickson RB (1999) Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness [In Process Citation]. Exp Cell Res247: 105–113 ArticleCASPubMed Google Scholar
Johnston SR, Haynes BP, Sacks NP, McKinna JA, Griggs LJ, Jarman M, Baum M, Smith IE and Dowsett M (1993) Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancer. Breast Cancer Res Treat28: 241–250 ArticleCASPubMed Google Scholar
Johnston SR, Lu B, Scott GK, Kushner PJ, Smith IE, Dowsett M and Benz CC (1999) Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance. Clin Cancer Res5: 251–256 CASPubMed Google Scholar
Karnik PS, Kulkarni S, Liu XP, Budd GT and Bukowski RM (1994) Estrogen receptor mutations in tamoxifen-resistant breast cancer. Cancer Res54: 349–353 CASPubMed Google Scholar
Kazanietz MG, Areces LB, Bahador A, Mischak H, Goodnight J, Mushinski JF and Blumberg PM (1993) Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C isozymes. Mol Pharmacol44: 298–307 CASPubMed Google Scholar
Labarca C and Paigen K (1980) A simple, rapid, and sensitive DNA assay procedure. Anal Biochem102: 344–352 ArticleCASPubMed Google Scholar
Lee W, Mitchell P and Tjian R (1987) Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell49: 741–752 ArticleCASPubMed Google Scholar
MacGregor Schafer J, Lee ES, O’Regan RM, Yao K and Jordan VC (2000) Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic in mice. Clin Cancer Res,
Manni A, Buckwalter E, Etindi R, Kunselman S, Rossini A, Mauger D, Dabbs D and Demers L (1996a) Induction of a less aggressive breast cancer phenotype by protein kinase c-α and -β overexpression. Cell Growth & Differentiation7: 1187–1198 CAS Google Scholar
Martin MB, Garcia-Morales P, Stoica A, Solomon HB, Pierce M, Katz D, Zhang S, Danielsen M and Saceda M (1995) Effects of 12-O-tetradecanoylphorbol-13-acetate on estrogen receptor activity in MCF-7 cells. J Biol Chem270: 25244–25251 ArticleCASPubMed Google Scholar
Morse-Gaudio M, Connolly JM and Rose DP (1998) Protein kinase C and its isoforms in human breast cancer cells: relationship to the invasive phenotype. Int J Oncol12: 1349–1354 CASPubMed Google Scholar
Ng T, Shima D, Squire A, Bastiaens PI, Gschmeissner S, Humphries MJ and Parker PJ (1999) PKCalpha regulates betal integrin-dependent cell motility through association and control of integrin traffic. Embo J18: 3909–3923 ArticleCASPubMedPubMed Central Google Scholar
Nishizuka Y (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science258: 607–614 ArticleCASPubMed Google Scholar
Nordeen SK (1988) Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques6: 454–8 CASPubMed Google Scholar
O’Brian C, Vogel VG, Singletary SE and Ward NE (1989) Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res49: 3215–3217 PubMed Google Scholar
Osborne CK (1993) Mechanisms for tamoxifen resistance in breast cancer: possible role of tamoxifen metabolism. J Steroid Biochem Mol Biol47: 83–89 ArticleCASPubMed Google Scholar
Philips A, Chalbos D and Rochefort H (1993) Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis [published erratum appears in J Biol Chem 1993 Dec 5;268(34):26032]. J Biol Chem268: 14103–14108 CASPubMed Google Scholar
Pink JJ, Jiang SY, Fritsch M and Jordan VC (1995) An estrogen-independent MCF-7 breast cancer cell line which contains a novel 80-kilodalton estrogen receptor-related protein. Cancer Res55: 2583–2590 CASPubMed Google Scholar
Pink JJ, Bilimoria MM, Assikis J and Jordan VC (1996) Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivation [published erratum appears in Br J Cancer 1997;75(10):1557]. Br J Cancer74: 1227–1236 ArticleCASPubMedPubMed Central Google Scholar
Platet N, Prevostel C, Derocq D, Joubert D, Rochefort H and Garcia M (1998) Breast cancer cell invasiveness: correlation with protein kinase C activity and differential regulation by phorbol ester in estrogen receptor-positive and -negative cells. Int J Cancer75: 750–756 ArticleCASPubMed Google Scholar
Reifel-Miller AE, Conarty DM, KM V, PW I, DJ B and KA B (1996) Protein kinase C isozymes differentially regulate promoters containing PEA-3/12-O-tetradecanoylphorbol-13-acetate response element motifs. J Biol Chem271: 21666–21671 ArticleCASPubMed Google Scholar
Saceda M, Knabbe C, Dickson RB, Lippman ME, Bronzert D, Lindsey RK, Gottardis MM and Martin MB (1991) Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate. J Biol Chem266: 17809–17814 CASPubMed Google Scholar
Smith LM, Wise SC, Hendricks DT, Sabichi AL, Bos T, Reddy P, Brown PH and Birrer MJ (1999) cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene18: 6063–6070 ArticleCASPubMed Google Scholar
Sun XG and Rotenberg SA (1999) Overexpression of protein kinase Calpha in MCF-10A human breast cells engenders dramatic alterations in morphology, proliferation, and motility [In Process Citation]. Cell Growth Differ10: 343–352 CASPubMed Google Scholar
Tonetti DA and Jordan VC (1995) Possible mechanisms in the emergence of tamoxifen-resistant breast cancer. Anticancer Drugs6: 498–507 ArticleCASPubMed Google Scholar
Tonetti DA, Horio M, Collart FR and Huberman E (1992) Protein kinase C beta gene expression is associated with susceptibility of human promyelocytic leukemia cells to phorbol ester-induced differentiation. Cell Growth Differ3: 739–745 CASPubMed Google Scholar
Ways DK, Kukoly CA, deVente J, Hooker JL, Bryant WO, Posekany KJ, Fletcher DJ, Cook PP and Parker PJ (1995) MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J Clin Invest95: 1906–1915 ArticleCASPubMedPubMed Central Google Scholar
Webb P, Lopez GN, Uht RM and Kushner PJ (1995) Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol9: 443–456 CASPubMed Google Scholar
Wolf DM and Jordan VC (1994) The estrogen receptor from a tamoxifen stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain. Breast Cancer Res Treat31: 129–138 ArticleCASPubMed Google Scholar
Wolf DM, Langan-Fahey SM, Parker CJ, McCague R and Jordan VC (1993) Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites. J Natl Cancer Inst85: 806–812 ArticleCASPubMed Google Scholar
Wyss R, Fabbro D, Regazzi R, Borner C, Takahashi A and Eppenberger U (1987) Phorbol ester and epidermal growth factor receptors in human breast cancer. Anticancer Res7: 721–727 CASPubMed Google Scholar